XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2022   187,906      
Beginning balance at Dec. 31, 2022 $ (294,597) $ 1,879 $ 1,158,118 $ 26 $ (1,454,620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (53,333)       (53,333)
Other comprehensive income (loss) 559     559  
Exercise of stock options, net (in shares)   702      
Exercise of stock options, net 3,502 $ 7 3,495    
Vesting of restricted stock units (in shares)   99      
Vesting of restricted stock units $ 0 $ 1 (1)    
Employee stock purchase plan sales, net (in shares) 176 176      
Employee stock purchase plan sales $ 1,575 $ 2 1,573    
Stock-based compensation expense 14,007   14,007    
Common stock, shares outstanding, ending balance (in shares) at Mar. 31, 2023   188,883      
Ending balance at Mar. 31, 2023 $ (328,287) $ 1,889 1,177,192 585 (1,507,953)
Common stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2023 205,771 205,771      
Beginning balance at Dec. 31, 2023 $ (455,528) $ 2,058 1,222,236 1,337 (1,681,159)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (35,379)       (35,379)
Other comprehensive income (loss) (566)     (566)  
Exercise of stock options, net (in shares)   176      
Exercise of stock options, net 552 $ 2 550    
Vesting of restricted stock units (in shares)   155      
Vesting of restricted stock units 0 $ 1 (1)    
Shares withheld for taxes for vesting of restricted stock units (in shares)   (8)      
Shares withheld for taxes for vesting of restricted stock units $ (38)   (38)    
Employee stock purchase plan sales, net (in shares) 251 251      
Employee stock purchase plan sales $ 1,129 $ 2 1,127    
Issuance of shares to directors in lieu of cash retainer (in shares)   2      
Issuance of shares to directors in lieu of cash retainer 11   11    
Stock-based compensation expense $ 13,652   13,652    
Common stock, shares outstanding, ending balance (in shares) at Mar. 31, 2024 206,347 206,347      
Ending balance at Mar. 31, 2024 $ (476,167) $ 2,063 $ 1,237,537 $ 771 $ (1,716,538)